AstraZeneca PLC in 1 story
The narratives AZN currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
AZN in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
AstraZeneca is building an obesity franchise around oral GLP-1 candidate AZD5004 and complementary cardiometabolic therapies.
Bear side
0 storiesNo bear-side stories for AZN yet.